#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Oropharyngeal cancer recurrent Waldenstrom's macroglobulinaemia refractory Emphysema Gaucher's disease type I Sexually transmitted disease Immunodeficiency Dilated cardiomyopathy Choroid melanoma Asthma Anti-myelin-associated glycoprotein antibodies positive Uveitis Glycogen storage disease type II Skin angiosarcoma Thalassaemia alpha Angiosarcoma More trials…

    Learn about Rare Diseases

    Loeys-Dietz syndrome – Life with Disease Immunodeficiency congenital – Life with Disease Optic glioma Waldenstrom’s macroglobulinaemia recurrent – Diagnostics Synovial sarcoma metastatic – Life with Disease Friedreich’s ataxia – Diagnostics Glomerulonephritis membranous – Basic Information Cystic fibrosis lung – Treatment Rett syndrome – Life with Disease Familial amyotrophic lateral sclerosis – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ILOPROST Imatinib AGA2118 Lactulose Fianlimab Azd8421 Somatropin Glimepiride Pilocarpine Hydrochloride Mercaptopurine POLYMYXIN B SULFATE Ltx-315 Imgn151 Human Serum Albumin 5% Amg 193 Bevacizumab Pemetrexed Darolutamide BMS-986365 Cenobamate More therapies…

    Learn about Your Condition

    SAPHO syndrome Synovial sarcoma recurrent Endometrial cancer stage IV Eosinophilic oesophagitis Menopausal symptoms Short-bowel syndrome Trigeminal neuralgia Hydrocele Chondrosarcoma Coagulopathy Multifocal motor neuropathy Bacterial prostatitis Primary hypercholesterolaemia Neonatal asphyxia Scoliosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Investigative Techniques

  • Study of flortaucipir and florbetapir in patients with memory disorders including Alzheimer’s disease and dementia

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Flortaucipir (18F)
    • Florbetapir (18F)
    France

  • Comparing Sphenopalatine Block Using Lidocaine and Prilocaine to Blood Patch for Patients with Post-Dural Puncture Syndrome

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Anhydrous Lidocaine Hydrochloride
    • Prilocaine
    • Lidocaine
    France

  • Study of drug combination therapy after surgery in patients with resectable pancreatic ductal adenocarcinoma using lab-grown mini-tumors to guide treatment selection

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Adenocarcinoma pancreas
    Investigated Drugs:
    • Calcium Folinate
    • Capecitabine
    • Fluorouracil
    Germany

  • Study on Metabolic Impairment in ALS and TIA Patients Using Hyperpolarized Pyruvate MRI

    Recruiting

    2 1 1
    Investigated Diseases:
    • Transient ischaemic attack
    • Amyotrophic lateral sclerosis
    Investigated Drugs:
    • Pyruvic Acid
    Denmark

  • Study on Brain Inflammation in Schizophrenia Patients Using 18F-DPA-714

    Recruiting

    4 1 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • N,N-Diethyl-2-(2-(4-(2[(18)F]-Fluoroethoxy)Phenyl)5,7Dimethylpyrazolo[1,5A]Pyrimidin-3-Yl)Acetamide
    France

  • Study on Pneumococcal Vaccine Response in Healthy Volunteers Using Pneumococcal Polysaccharide Conjugate Vaccine and Drug Combination

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Pneumococcal Polysaccharide Serotype 1 Conjugated To Crm197 Adsorbed On Aluminium Phosphate
    • Pneumococcal Polysaccharide Serotype 10A Conjugated To Crm197 Adsorbed On Aluminium Phosphate
    • Pneumococcal Polysaccharide Serotype 11A Conjugated To Crm197 Adsorbed On Aluminium Phosphate
    The Netherlands
1 2 3 … 7
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!